Global epidemiology and burden of hepatitis C
Open accessAbstract
Despite rapid progress in our knowledge of hepatitis C virology and pathogenesis, little is known about the current and future burden of this infection throughout the world. Prevalence and population-based studies have suggested that complications of the liver disease associated with chronic hepatitis C infection may potentially require substantial health care resources and generate very high costs for medical systems in the United States, Europe and worldwide. Careful understanding and assessment of hepatitis C health and economic burdens are likely to guide better programs for the management of infected individuals and the prevention of complications.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Currently, Egypt has the highest prevalence of chronic hepatitis C infection in the world.
“Currently, Egypt has the highest prevalence of chronic hepatitis C infection in the world [43,44].”
From Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis (2014) · cites this paper as [44]
Cites
Murray, C. J. L., & López, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007 · see citing works
(1996) · Cited by 6,884 · see citing works
Higgins, S. M. F., Macken, A. P., Cullen, W., Saunders, J., Dunne, C. P., & O’Gorman, C. S. (2013) · PubMed · doi:10.34961/9953 · Cited by 4,806 · see citing works
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · see citing works
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043 · see citing works
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 3,010 · see citing works
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,989 · see citing works
Schaff, Z., & Csmos, G. (1994) · Cited by 1,869 · see citing works
The global burden of disease, 1990–2020
López, A. D., & Murray, C. C. J. L. (1998) · Nature Medicine · doi:10.1038/3218 · Cited by 1,613 · see citing works
(U.S.), C. F. D. C. A. P. (1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,213 · see citing works
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., Khoby, T. E., Abdel-Wahab, Y., Ohn, E. S. A., Anwar, W., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06527-7 · Cited by 1,131 · see citing works
Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends
Wasley, A., & Alter, M. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9506 · Cited by 986 · see citing works
Global surveillance and control of hepatitis C
(1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.6120139.x · Cited by 903 · see citing works
(1997) · Hepatology · doi:10.1002/hep.510260701 · Cited by 583 · see citing works
Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S. (2000) · Hepatology · doi:10.1002/hep.510310332 · Cited by 523 · see citing works
Murray, C. J. L., & López, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07494-6 · Cited by 466 · see citing works
Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy
Bronowicki, J., Venard, V., Botté, C., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370404 · Cited by 435 · see citing works
Global surveillance and control of hepatitis C
Lavanchy, D., Purcell, R. H., Hollinger, F. B., et al. (1999) · UCL Discovery (University College London) · Cited by 433 · see citing works
Guadagnino, V., Stroffolini, T., Rapicetta, M., et al. (1997) · Hepatology · doi:10.1002/hep.510260431 · Cited by 383 · see citing works
Glynn, S. A. (2000) · JAMA · doi:10.1001/jama.284.2.229 · Cited by 288 · see citing works
Hepatitis C--global prevalence (update).
(1999) · PubMed · Cited by 270 · see citing works
Brazier, J. E., & Deverill, M. (1999) · Health Economics · doi:10.1002/(sici)1099-1050(199902)8:1 · Cited by 189 · see citing works
Hepatitis C: global prevalence.
(1997) · PubMed · Cited by 179 · see citing works
Transmission of hepatitis C in an isolated area in Japan: Community-acquired infection
KIYOSAWA, K., Tanaka, E., Sodeyama, T., Yoshizawa, K., Yabu, K., Furuta, K., Imai, H., Nakano, Y., Usuda, S., Uemura, K., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90416-2 · Cited by 161 · see citing works
The Prevalence of Hepatitis C Virus Antibodies among Hemodialysis Patients
Zeldis, J. B., Depner, T. A., Kuramoto, I. K., et al. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-12-958 · Cited by 161 · see citing works
Outcome of Hospital Care of Liver Disease Associated With Hepatitis C in the United States
Kim, W. R., Gross, J. B., Poterucha, J. J., Locke, R. G., & Dickson, R. E. (2001) · Hepatology · doi:10.1053/jhep.2001.20798 · Cited by 106 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758 · see citing works
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572 · see citing works
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Mokdad, A. A., Lopez, A. D., Shahraz, S., Lozano, R., Mokdad, A. H., Stanaway, J., Murray, C. J., & Naghavi, M. (2014) · BMC Medicine · doi:10.1186/s12916-014-0145-y · Cited by 1,129 · see citing works
- Authors
- Ray Kim, W.
- Venue
- Microbes and Infection
- Publisher
- Elsevier BV
- Published
- 2002-10
- Volume
- 4
- Issue
- 12
- Pages
- 1219-1225
- ISSN
- 1286-4579 (ISSN-L)
- OpenAlex
- W2025564897
- Cited by
- 149
- References
- 26
- Citations by year
- 2024: 3 · 2023: 2 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 8 · 2017: 3 · 2016: 6 · 2015: 10 · 2014: 15 · 2013: 13 · 2012: 10
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Microbes and Infection (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 34238, R01DK034238)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Surgery › Helicobacter pylori-related gastroenterology studies
- Keywords
- hepatitis C, global burden of disease, HCV prevalence, chronic hepatitis C, liver disease complications, health care costs, economic burden, disease prevention, epidemiology
- MeSH terms
- Hepatitis C, Humans, Public Health, Global Health, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
